We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$214M
AUM Growth
+$4.1M
Cap. Flow
-$758K
Cap. Flow %
-0.35%
Top 10 Hldgs %
10.99%
Holding
242
New
22
Increased
21
Reduced
29
Closed
23

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$2.67M
2
XOM icon
ExxonMobil
XOM
+$1.63M
3
CRM icon
Salesforce
CRM
+$1.48M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.45M
5
AMZN icon
Amazon
AMZN
+$1.42M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.78M
2
SCHW
Charles Schwab
SCHW
+$1.56M
3
HP icon
Helmerich & Payne
HP
+$1.45M
4
EXPD icon
Expeditors International
EXPD
+$1.34M
5
BKNG icon
Booking.com
BKNG
+$1.3M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 14.4%
3 Healthcare 14.07%
4 Industrials 12.13%
5 Consumer Discretionary 11.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
176
Pfizer
PFE
$140B
$731K 0.34%
+21,868
New +$698K
HCR
177
DELISTED
Hi-Crush Inc. Common Stock
HCR
$729K 0.34%
55,800
– –
EPAM icon
178
EPAM Systems
EPAM
$4.69B
$723K 0.34%
11,242
– –
EXR icon
179
Extra Space Storage
EXR
$31.2B
$717K 0.34%
+7,746
New +$700K
ANDV
180
DELISTED
Andeavor
ANDV
$713K 0.33%
9,517
– –
KYNB
181
Kyntra Bio
KYNB
$28.5M
$705K 0.33%
1,719
– –
ITCI
182
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$702K 0.33%
18,088
– –
EBS icon
183
Emergent Biosolutions
EBS
$375M
$693K 0.32%
24,637
– –
ORLY icon
184
O'Reilly Automotive
ORLY
$72.4B
$674K 0.32%
37,320
-12,810
-26% -$226K
MOH icon
185
Molina Healthcare
MOH
$10.3B
$673K 0.32%
13,496
– –
IXYS
186
DELISTED
IXYS Corp
IXYS
$673K 0.32%
65,632
– –
CLR
187
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$672K 0.31%
+14,834
New +$583K
AMRI
188
DELISTED
Albany Molecular Research Inc
AMRI
$667K 0.31%
49,644
– –
CMCSA icon
189
Comcast
CMCSA
$79.1B
$659K 0.31%
20,208
-27,000
-57% -$838K
VRTU
190
DELISTED
Virtusa Corporation
VRTU
$656K 0.31%
22,720
– –
LIOX
191
DELISTED
Lionbridge Technologies
LIOX
$644K 0.3%
162,997
– –
WNR
192
DELISTED
Western Refining Inc
WNR
$644K 0.3%
31,200
– –
CPRI icon
193
Capri Holdings
CPRI
$1.77B
$636K 0.3%
12,863
– –
SMCI icon
194
Super Micro Computer
SMCI
$19.5B
$619K 0.29%
249,290
– –
APD icon
195
Air Products & Chemicals
APD
$66.3B
$610K 0.29%
4,646
-4,588
-50% -$611K
BA icon
196
Boeing
BA
$165B
$610K 0.29%
+4,697
New +$612K
HON icon
197
Honeywell
HON
$77.1B
$605K 0.28%
+5,789
New +$595K
GWW icon
198
W.W. Grainger
GWW
$65.3B
$583K 0.27%
2,565
-1,200
-32% -$273K
TSRO
199
DELISTED
TESARO, Inc.
TSRO
$573K 0.27%
6,820
– –
KO icon
200
Coca-Cola
KO
$354B
$570K 0.27%
+12,583
New +$569K
6 7
8
9 10

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
ACA
American Capital Advisory Ketchum, Idaho $248M AUM 21.64% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
VWM
Vivid Wealth Management West Des Moines, Iowa $247M AUM 30.07% 1-Year Est. Return
AAG
Avalon Advisory Group Wexford, Pennsylvania $248M AUM 11.89% 1-Year Est. Return

Capital Impact Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Capital Impact Advisors held 242 positions worth $214M, up 2% from $210M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Capital Impact Advisors's Q2 2016 filing shows 22 new, 21 increased, 29 reduced and 23 closed positions. Its largest new stake was ExxonMobil: 18,463 shares worth $1.73M. The largest sale was Jazz Pharmaceuticals, an estimated $1.78M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Capital Impact Advisors's largest Q2 2016 buy was ExxonMobil: 18,463 shares worth $1.73M.
  • Capital Impact Advisors added most to United Therapeutics in Q2 2016, an estimated $2.67M increase.
  • Capital Impact Advisors's biggest Q2 2016 reduction was Jazz Pharmaceuticals, cutting an estimated $1.78M.
  • Capital Impact Advisors fully exited Charles Schwab in Q2 2016, selling an estimated $1.56M.
  • Capital Impact Advisors's ten largest holdings make up 11% of its $214M portfolio in Q2 2016.
  • Capital Impact Advisors opened 22 new positions and closed 23 in Q2 2016.
  • Capital Impact Advisors's portfolio value rose 2% quarter-over-quarter to $214M.

Based on Capital Impact Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.